Evidence map›Paper›PMID 26824300›Full record

ArticleChemical research in toxicology2016

Methemoglobin Formation and Characterization of Hemoglobin Adducts of Carcinogenic Aromatic Amines and Heterocyclic Aromatic Amines.

Khyatiben V Pathak, Ting-Lan Chiu, Elizabeth Ambrose Amin, Robert J Turesky

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Quo vadis blood protein adductomics?Archives of toxicology · 2022
    Review
  9. Article
  10. Metabolism and biomarkers of heterocyclic aromatic amines in humans.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Khyatiben V PathakMasonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Ting-Lan ChiuMasonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Elizabeth Ambrose AminMasonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Robert J TureskyMasonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
Chemical markers of heterocyclic aromatic amines for human biomonitoringR01CA122320 · NCI · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2007 to 2018
$4.8M
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in tobacR01CA134700 · NCI · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2010 to 2014
$2.1M
NCI NIH HHS CA-77598NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA122320NCI NIH HHS R01 CA134700NCI NIH HHS R01CA134700NCI NIH HHS R01CA134700-03S1
6 · The paper itself

Abstract

Arylamines (AAs) and heterocyclic aromatic amines (HAAs) are structurally related carcinogens formed during the combustion of tobacco or cooking of meat. They undergo cytochrome P450 mediated N-hydroxylation to form metabolites which bind to DNA and lead to mutations. The N-hydroxylated metabolites of many AAs also can undergo a co-oxidation reaction with oxy-hemolgobin (HbO2) to form methemoglobin (met-Hb) and the arylnitroso intermediates, which react with the β-Cys(93) chain of Hb to form Hb-arylsulfinamide adducts. The biochemistry of arylamine metabolism has been exploited to biomonitor certain AAs through their Hb arylsulfinamide adducts in humans. We examined the reactivity of HbO2 with the N-hydroxylated metabolites of 4-aminobiphenyl (ABP, HONH-ABP), aniline (ANL, HONH-ANL), and the HAAs 2-amino-9H-pyrido[2,3-b]indole (AαC, HONH-AαC), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP, HONH-PhIP), and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx, HONH-MeIQx). HONH-ABP, HO-ANL, and HONH-AαC induced methemoglobinemia and formed Hb sulfinamide adducts. However, HONH-MeIQx and HONH-PhIP did not react with the oxy-heme complex, and met-Hb formation and chemical modification of the β-Cys(93) residue were negligible. Molecular modeling studies showed that the distances between the H-ON-AA or H-ON-HAA substrates and the oxy-heme complex of HbO2 were too far away to induce methemoglobinemia. Different conformational changes in flexible helical and loop regions around the heme pocket induced by the H-ON-AA or H-ON-HAAs may explain the different proclivities of these chemicals to induce methemoglobinemia. Hb-Cys(93β) sulfinamide and sulfonamide adducts of ABP, ANL, and AαC were identified, by Orbitrap MS, following the proteolysis of Hb with trypsin, Glu-C, or Lys-C. Hb sulfinamide and sulfonamide adducts of ABP were identified in the blood of mice exposed to ABP, by Orbitrap MS. This is the first report of the identification of intact Hb sulfinamide adducts of carcinogenic AAs in vivo. The high reactivity of HONH-AαC with HbO2 suggests that the Hb sulfinamide adduct of AαC may be a promising biomarker of exposure to this HAA in humans.

Indexed as

AminesAnimalsCarcinogensHemoglobinsHeterocyclic CompoundsHumansHydrocarbons, AromaticMaleMethemoglobinMiceMice, Inbred StrainsAminesCarcinogensHemoglobinsHeterocyclic CompoundsHydrocarbons, AromaticMethemoglobin

Identifiers

PMID26824300
PMCPMC4801648
OpenAlexW2286986007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.